Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
---|
05/22/2007 | US7220734 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists |
05/18/2007 | WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
05/18/2007 | WO2006099058A3 Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use |
05/18/2007 | WO2006081807A3 Method for the production of losartan |
05/18/2007 | CA2627719A1 [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto |
05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
05/17/2007 | US20070111274 Alkali metal or ammonium salts of sulfonated 3-(p-phenylazophenyl)-2,5-diphenyl-2H-tetrazolium compounds; quantitative analysis of dehydrogenase |
05/16/2007 | CN1964955A Small molecules for treatment of hypercholesterolemia and related diseases |
05/16/2007 | CN1962596A Ketone compounds and compositions for cholesterol management and related uses |
05/15/2007 | US7217825 Neutralizing an acidified solution of a water-miscible solvent and 2-butyl-3-[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl methyl]-1,3-diazaspiro[4.4]non-1-ene-4-one, a novel intermediate of a Suzuki coupling reaction; acidifying and cooling the second solution and recovering irbesartan |
05/15/2007 | US7217728 For therapy of reperfusion injury |
05/10/2007 | WO2007009637A3 Complexes containing perfluoroalkyl, their use as contrast media for nmr, x-ray and radio diagnosis and radiotherapy |
05/10/2007 | WO2006120574A3 Analogs of 4-hydroxyisoleucine and uses thereof |
05/10/2007 | WO2006002873A3 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri ) |
05/10/2007 | US20070106080 Process for production of 1-aryl-5-(trifluoromethyl)-1h-tetrazoles |
05/10/2007 | US20070105958 Compounds for the treatment of metabolic disorders |
05/10/2007 | US20070105926 Tetrazoyloxime derivative and agricultural chemical containing the same as active ingredient |
05/10/2007 | US20070105924 Vigabatrin bioisoteres and related methods of use |
05/10/2007 | US20070105858 Retinoic acid mimetic anilides |
05/09/2007 | EP1781627A2 A method for preparing irbesartan and intermediates thereof |
05/09/2007 | CN1314672C 5-substituted aromatic laydrocarbon tetrazole production method |
05/08/2007 | US7214545 Element-coded affinity tags |
05/08/2007 | CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
05/03/2007 | WO2007048771A1 Arylurea derivatives as modulators of chemokine receptor activity |
05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
05/03/2007 | US20070098643 Oligomers of gadolinium chelates, their applicationascontrast products in magnetic resonance imaging and their synthesis intermediates |
05/03/2007 | CA2626324A1 Arylurea derivatives as modulators of chemokine receptor activity |
05/02/2007 | EP1778651A2 Multivalent chelators for modifying and organizing of target molecules |
05/02/2007 | EP1778650A1 Process for preparing candesartan cilexetil |
05/02/2007 | EP1480979B1 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates |
05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
05/01/2007 | US7211241 Cascade polymer complexes that contain complexing ligands of general formula I A-(X (Y-(Z-(W KW)Z)y)x) (I), in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand |
05/01/2007 | CA2138675C Catecholamine surrogates useful as .beta.3 agonists |
04/26/2007 | WO2007047447A2 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
04/26/2007 | WO2007045675A1 Process for obtaining valine derivatives useful for obtaining a pharmaceutically active compound |
04/26/2007 | WO2007045370A1 Tetrazol derivatives and their use for the treatment of cardiovascular diseases |
04/26/2007 | WO2007045369A1 Difluorophenol derivatives and their use |
04/26/2007 | WO2007017267A3 Novel compounds |
04/26/2007 | WO2007009638A3 Complexes containing perfluoroalkyl, method for the production and use thereof |
04/26/2007 | WO2006133216A3 4-substituted arylamine derivatives and their use in pharmaceutical compositions |
04/26/2007 | US20070093542 Process for the preparation of valsartan and intermediates thereof |
04/26/2007 | US20070093487 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
04/26/2007 | DE112005001305T5 Gaserzeugungsmittel und Synthese And synthesis gas generating agent |
04/26/2007 | DE102005050497A1 Difluorphenol-Derivate und ihre Verwendung Difluorophenol derivatives and their use |
04/26/2007 | DE102005050375A1 Tetrazol-Derivate und ihre Verwendung Tetrazole derivatives and their use |
04/26/2007 | CA2625918A1 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
04/25/2007 | EP1777224A2 A process for the preparation of angiotensin II antagonistic compounds |
04/25/2007 | CN1953966A Anticancer agent |
04/24/2007 | USRE39590 3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione; useful for general or pre-emergent or post-emergent control of undesired plant species and defoliants at very low concentrations |
04/24/2007 | US7208140 Trimeric macrocyclic substituted benzene derivatives |
04/24/2007 | CA2075173C Compounds and methods for inhibition of hiv and related viruses |
04/19/2007 | WO2007044724A2 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3 |
04/19/2007 | WO2007042506A1 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
04/19/2007 | US20070088004 MAO-B inhibitors useful for treating obesity |
04/19/2007 | CA2625207A1 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
04/19/2007 | CA2623759A1 Pyridopyrimidinone inhibitors of pim 1 and/or pim-3 |
04/18/2007 | EP1773792A1 Indanone potentiators of metabotropic glutamate receptors |
04/18/2007 | EP1773125A1 5-iodotetrazoles |
04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
04/18/2007 | CN1310905C Antivirally active heterocyclic azahexane derivatives |
04/18/2007 | CN1310642C Methods and compositions to enhance white blood cell count |
04/17/2007 | US7205267 Use of transition metal complexes as bleach catalysts in laundry detergents and cleaning compositions |
04/11/2007 | EP1307237B1 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
04/11/2007 | EP0950656B1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
04/10/2007 | US7202367 Process for arylating or vinylating or alkynating a nucleophilic compound |
04/10/2007 | CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists |
04/05/2007 | WO2007037685A1 Novel antibiotics comprising bis(1-aryl-5-tetraz0lyl)methane derivatives |
04/04/2007 | EP1769796A1 Novel antibiotics comprising bis(1-aryl-5-tetrazolyl)methane derivatives |
04/04/2007 | CN1308297C Phenyl sulfamate derivatives |
04/04/2007 | CN1307992C Eye drops containing tetrazole derivative |
04/03/2007 | US7199144 Containing less than about 5000 ppm residual solvent by trituration in water |
03/29/2007 | WO2007035964A2 Vigabatrin bioisoteres and related methods of use |
03/29/2007 | WO2007034251A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
03/29/2007 | US20070072923 Process for producing 2'-(1h-tetrazol-5-yl)biphenyl-4-carbaldehyde |
03/29/2007 | US20070072922 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
03/29/2007 | US20070072909 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
03/29/2007 | US20070072900 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
03/29/2007 | CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
03/28/2007 | EP1765826A2 Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles |
03/28/2007 | EP1765812A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
03/28/2007 | EP1765332A2 Trisubstituted nitrogen modulators of tyrosine phosphatases |
03/28/2007 | EP0988305B1 A PROCESS FOR THE PREPARATION OF 5H,9bH-2a, 4a,7,9a-OCTAHYDROTETRAAZACYCLOOCTA [cd] PENTALENE |
03/28/2007 | CN1938266A Sulfonamide compounds for the treatment of neurodegenerative disorders |
03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
03/22/2007 | WO2007033002A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
03/22/2007 | US20070066819 Process for the preparation of benzotriazepine derivatives |
03/22/2007 | US20070066586 Aniline derivatives |
03/22/2007 | CA2621949A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
03/22/2007 | CA2619955A1 Process for preparing valsartan |
03/21/2007 | CN1931857A Prepn process of 5-losartan carboxylate |
03/20/2007 | US7192982 Modulators of peroxisome proliferator activated receptors |
03/15/2007 | WO2007029587A1 β SECRETASE INHIBITOR |
03/15/2007 | WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
03/15/2007 | WO2007029021A1 1,5-substituted tetrazoles as therapeutic compounds |
03/15/2007 | WO2006050444A9 Water-based synthesis of poly(tetrazoles) |
03/15/2007 | US20070060630 Producing an alkoxy(tetrazol-1-yl)benzaldehyde compound by reacting the corresponding 1-(alkoxyphenyl)-1H-tetrazole compound with hexamethylenetetramine in a sulfonic acid' solvent, followed by hydrolysis; safe, efficient process; intermediate for analgesics or anti-inflammatory agents |
03/15/2007 | US20070060591 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections |
03/15/2007 | CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
03/14/2007 | CN1930153A Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents |
03/14/2007 | CN1304381C Chemical synthesis method of 1,2,3,4-tetra nitroazole kind compound |